Establishes the Genetic Information Privacy Act, which would require a direct-to-consumer genetic testing company, as defined, to provide a consumer with certain information regarding the company’s policies and procedures regarding use of genetic data.
Mandates all insurance contracts, plans or policies provide insurance coverage for the expense of testing and treating infertility, including preimplantation genetic testing (PGT), in conjunction with in vitro fertilization (IVF).
Mandates insurance policies, provides coverage to diagnose & treat infertility for women between 25 & 42 years, including pre-implantation genetic diagnosis (PGD) in conjunction with in vitro fertilization (IVF).
Mandates insurance policies, provides coverage to diagnose & treat infertility for women between 25 & 42 years, including pre-implantation genetic diagnosis (PGD) in conjunction with in vitro fertilization (IVF).
Amends the statutory provisions regarding domestic and foreign insurers and insurer examinations to provide provisions with regard to cybersecurity events involving Rhode Island consumers.
Amends the statutory provisions regarding domestic and foreign insurers and insurer examinations to provide provisions with regard to cybersecurity events involving Rhode Island consumers.
Prohibits utility companies from limiting eligibility of net metering site based on prior consumption and requires excess energy not consumed to be credited to consumer. Also amends definition of excess renewable net-metering credit.
Prohibits utility companies from limiting eligibility of net metering site based on prior consumption and requires excess energy not consumed to be credited to consumer. Also amends definition of excess renewable net-metering credit.
Prohibits utility companies from limiting the eligibility of a net metering site based on prior consumption and requires excess energy not consumed under the net metering system to be credited to the consumer.
Mandates all insurance plans provide insurance coverage for diagnosing and treating infertility for women between the ages of 25 and 42 years including preimplantation genetic diagnosis (PGD) in conjunction with in vitro fertilization (IVF).